<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00189943</url>
  </required_header>
  <id_info>
    <org_study_id>MVA-POX-001</org_study_id>
    <secondary_id>Bavarian Nordic</secondary_id>
    <nct_id>NCT00189943</nct_id>
  </id_info>
  <brief_title>Study on Safety, Tolerability and Immunogenicity of an MVA Vaccine Administered to Healthy Subjects</brief_title>
  <official_title>Phase I Study on Safety, Tolerability and Immunogenicity of the MVA-BN Vaccine Administered to Healthy Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bavarian Nordic</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bavarian Nordic</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect information on the safety, tolerability and
      immunogenicity of an investigational smallpox vaccine at different doses and using different
      routes of administration in vaccinia-naive and vaccinated healthy volunteers
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2001</start_date>
  <completion_date>July 2003</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>90</enrollment>
  <condition>Smallpox</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MVA-BN</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male subjects, aged 20 - 55 years

          -  Signed informed consent

        Exclusion Criteria:

          -  Prior vaccination against smallpox (study part I only)

          -  Abnormalities suspicious of any underlying disease, detected at routine tests prior to
             study inclusion.

          -  Any immune modifying therapy within 4 weeks prior to entry

          -  Participation in any other investigating drug trial

          -  Known allergy to a component which may be part of the vaccine

          -  Allergic reaction or any other severe adverse effects experienced after previous
             smallpox vaccination (study Part II only)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karl M Eckl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>PharmPlanNet Cantract Research GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>PharmPlanNet Contract Research GmbH</name>
      <address>
        <city>Moenchengladbach</city>
        <zip>41061</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 12, 2005</study_first_submitted>
  <study_first_submitted_qc>September 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>September 12, 2005</last_update_submitted>
  <last_update_submitted_qc>September 12, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 19, 2005</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Smallpox</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 25, 2016</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>January 27, 2016</submitted>
    <returned>February 23, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

